Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC GLPG3970 | 2403733-82-2 | C25H27F3N4O4 | 250 MG
SDP

Supplier:  Medchemexpress LLC 250MGHY150203

Encompass_Preferred

GLPG3970 is a first-in-class SIK2/SIK3 inhibitor intended for research related to inflammation and autoimmune diseases. It has been investigated in clinical trials for conditions such as Systemic Lupus Erythematosus, Ulcerative Colitis, and Rheumatoid Arthritis.

  • Acts as a SIK2/SIK3 inhibitor
  • Supports research in inflammation and autoimmune diseases
  • Induces IL-10 expression in human CD14+ monocytes with an EC50 of 1087 nM
  • Reduces LPS-stimulated TNF-alpha production in human CD14+ monocytes with an IC50 of 133 nM
  • Decreases ear thickness in murine models of psoriatic-like epidermal hyperplasia
  • Improves clinical manifestations in murine collagen-antibody induced arthritis models
  • Reduces disease activity index in mice T cell transfer models
  • Investigated in clinical trials for various conditions
  • High purity: 99.70%
  • Solid, white to off-white appearance

Catalog No. 50-003-75956


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.